ASND logo

Ascendis Pharma A/S (ASND) Retained earnings

annual retained earnings:

-$2.65B-$135.17M(-5.37%)
December 31, 2024

Summary

  • As of today (August 18, 2025), ASND annual retained earnings is -$2.65 billion, with the most recent change of -$135.17 million (-5.37%) on December 31, 2024.
  • During the last 3 years, ASND annual retained earnings has fallen by -$1.04 billion (-64.85%).
  • ASND annual retained earnings is now -1677.97% below its all-time high of $167.97 million, reached on December 31, 2016.

Performance

ASND Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherASNDbalance sheet metrics

quarterly retained earnings:

-$3.13B-$259.25M(-9.03%)
June 1, 2025

Summary

  • As of today (August 18, 2025), ASND quarterly retained earnings is -$3.13 billion, with the most recent change of -$259.25 million (-9.03%) on June 1, 2025.
  • Over the past year, ASND quarterly retained earnings has dropped by -$3.13 billion (-100.00%).
  • ASND quarterly retained earnings is now -1593.31% below its all-time high of $209.60 million, reached on September 30, 2017.

Performance

ASND quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherASNDbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

ASND Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-5.4%-100.0%
3 y3 years-64.8%-84.7%
5 y5 years-286.3%-262.1%

ASND Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-64.8%at low<-9999.0%at low
5 y5-year-286.3%at low<-9999.0%at low
alltimeall time-1678.0%at low-1593.3%at low

ASND Retained earnings History

DateAnnualQuarterly
Jun 2025
-
-$3.13B(+9.0%)
Mar 2025
-
-$2.87B(+8.3%)
Dec 2024
-$2.65B(+5.4%)
-$2.65B(-6.8%)
Sep 2024
-
-$2.84B(<-9900.0%)
Jun 2024
-
$0.00(-100.0%)
Mar 2024
-
-$2.58B(+2.7%)
Dec 2023
-$2.52B(+26.7%)
-$2.52B(+7.8%)
Sep 2023
-
-$2.33B(<-9900.0%)
Jun 2023
-
$0.00(-100.0%)
Mar 2023
-
-$2.13B(+7.1%)
Dec 2022
-$1.99B(+23.5%)
-$1.99B(+13.3%)
Sep 2022
-
-$1.75B(+3.5%)
Jun 2022
-
-$1.69B(-1.1%)
Mar 2022
-
-$1.71B(+6.5%)
Dec 2021
-$1.61B(+27.5%)
-$1.61B(+6.1%)
Sep 2021
-
-$1.52B(+4.1%)
Jun 2021
-
-$1.46B(+13.3%)
Mar 2021
-
-$1.28B(+1.9%)
Dec 2020
-$1.26B(+83.7%)
-$1.26B(+20.6%)
Sep 2020
-
-$1.05B(+20.9%)
Jun 2020
-
-$864.34M(+16.8%)
Mar 2020
-
-$740.25M(+7.9%)
Dec 2019
-$686.21M
-$686.21M(+18.5%)
Sep 2019
-
-$578.85M(+0.5%)
DateAnnualQuarterly
Jun 2019
-
-$576.06M(+14.8%)
Mar 2019
-
-$501.85M(+11.6%)
Dec 2018
-$449.61M(+42.3%)
-$449.61M(+7.1%)
Sep 2018
-
-$419.68M(+9.8%)
Jun 2018
-
-$382.21M(+2.0%)
Mar 2018
-
-$374.59M(+18.5%)
Dec 2017
-$316.06M(-288.2%)
-$316.06M(-250.8%)
Sep 2017
-
$209.60M(+76.6%)
Jun 2017
-
$118.67M(-17.7%)
Mar 2017
-
$144.12M(-14.2%)
Dec 2016
$167.97M(+39.0%)
$167.97M(+149.7%)
Sep 2016
-
$67.26M(-22.4%)
Jun 2016
-
$86.63M(-16.2%)
Mar 2016
-
$103.42M(-14.4%)
Dec 2015
$120.88M(+152.5%)
$120.88M(-12.2%)
Sep 2015
-
$137.60M(-3.2%)
Jun 2015
-
$142.09M(+196.8%)
Dec 2014
$47.87M(+1527.9%)
$47.87M(-1624.3%)
Sep 2014
-
-$3.14M(-495.5%)
Jun 2014
-
$794.10K(-73.0%)
Dec 2013
$2.94M(-214.6%)
$2.94M(-1895.2%)
Sep 2013
-
-$163.80K(-150.6%)
Jun 2013
-
$323.70K
Dec 2012
-$2.57M(-38.0%)
-
Dec 2011
-$4.14M
-

FAQ

  • What is Ascendis Pharma A/S annual retained earnings?
  • What is the all time high annual retained earnings for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S annual retained earnings year-on-year change?
  • What is Ascendis Pharma A/S quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S quarterly retained earnings year-on-year change?

What is Ascendis Pharma A/S annual retained earnings?

The current annual retained earnings of ASND is -$2.65B

What is the all time high annual retained earnings for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high annual retained earnings is $167.97M

What is Ascendis Pharma A/S annual retained earnings year-on-year change?

Over the past year, ASND annual retained earnings has changed by -$135.17M (-5.37%)

What is Ascendis Pharma A/S quarterly retained earnings?

The current quarterly retained earnings of ASND is -$3.13B

What is the all time high quarterly retained earnings for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high quarterly retained earnings is $209.60M

What is Ascendis Pharma A/S quarterly retained earnings year-on-year change?

Over the past year, ASND quarterly retained earnings has changed by -$3.13B (-100.00%)
On this page